Irish Chamber Vice President, Tom McCool, will be presenting at an international conference on applied behavior analysis on the credentialing of behavior therapists in Paris.
Nov14Tue
Nov07Tue
ICON contributes to major European research study that aims to improve treatment for traumatic brain injury
Recommendations from the longitudinal observational research study will be presented today at the European Parliament
Dublin, Ireland, 7 November 2017 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has contributed to a complex pan-European traumatic brain injury (TBI) research study involving over 4,500 patients in 65 sites in 20 European countries. ICON provided site management and source data verification (SDV) services to the study, which was supported by the European Union and led by Professor Andrew Maas from the University Hospital Antwerp (Belgium) and Professor David Menon from the University of Cambridge (UK). ICON’s Dr. Valérie Legrand, VP Project Management and a recognised expert in CNS, also provided clinical expertise as a member of the project’s Management Committee. The Lancet Neurology Commission on TBI is being launched at the European Parliament today and will set out clinical and research priorities and recommendations to address the varied challenges in TBI.
Congratulations to Deirdre McGlinchey, attorney at McGlinchey Stafford in New Orleans, who was appointed Honorary Consul of The Kingdom of The Netherlands.
Nov02Thu
